Is Ageing an Engineering Problem We Can Solve?

Have you ever wondered if growing older is inevitable, or if science could treat it like any other challenge to overcome? In 2025, emerging research suggests ageing is more of an engineering issue than a fixed fate.

What Makes Ageing an Engineering Challenge?

Biomedical scientist Avi Roy argues that ageing is not destiny but an engineering problem. He compares it to historical successes, such as vaccines that dramatically reduced child mortality.

For most of human history, 40% of children died before age five. Engineers and scientists solved this through innovations like vaccines, which act as "software upgrades" for the immune system. Ageing is understood through an expanded framework of around a dozen interconnected biological hallmarks, including telomere attrition and cellular waste accumulation. Targeting these mechanisms could slow or modulate aspects of the ageing process.

How Are Scientists Engineering Solutions in 2025?

A breakthrough from Tokyo Metropolitan University introduces a label-free method to identify senescent cells using electric fields.

Researchers developed frequency-modulated dielectrophoresis (FM-DEP), which detects differences in cell movement under alternating electric fields. Senescent cells exhibit distinct cutoff frequencies due to membrane lipid changes.

This rapid, non-damaging technique outperforms traditional labeling and supports research into ageing-related conditions like Alzheimer’s and diabetes.

Why Does This Matter for Better Ageing?

These developments align with scientific efforts toward ‘negligible senescence’—the goal of maintaining youthful function over extended periods rather than indefinitely.

Interventions like GLP-1 agonists, originally for diabetes, now show promise in reducing inflammation and supporting metabolic health for longevity. Personalised approaches, including biomarker monitoring and exercise, empower individuals to manage ageing risks.

How Are 2025 Breakthroughs Impacting the Engineering Better Ageing Market?

At Next Move Strategy Consulting, we observe how these 2025 advancements fuel the Engineering Better Ageing Market—a sector encompassing biotechnology, diagnostics, and personalised health solutions. The FM-DEP method enhances drug screening and regenerative medicine research, potentially streamlining the development of senescence-targeting therapies and accelerating innovation in age-related pharmaceuticals.

Meanwhile, recognising ageing’s interconnected hallmarks encourages research into repurposing existing drugs, such as GLP-1 agonists, for healthy ageing outcomes, expanding metabolic health markets and creating opportunities in wearables and AI-driven biomarker tools.

Large-scale data initiatives, such as leveraging digital health records for in-silico trials, could accelerate market growth by reducing costs and timelines for new interventions. These shifts add value by driving demand for precise diagnostics, biotech investments, and consumer health products focused on healthy lifespan extension rather than mere disease treatment.

Competitive Landscape of the Engineering Better Ageing Market

Various key market players operating in the engineering better ageing industry includes Altos Labs, Inc., Unity Biotechnology, Inc., AgeX Therapeutics, Inc., Repair Biotechnologies, Inc., Mount Sinai Health System, Genflow Biosciences Plc, Christian Dior SE., and others. These market players are adopting various strategies such as research and developments to introduce innovative reverse ageing solutions and other diagnostic tools related to the market.

What Next Steps Can You Take Toward Better Ageing?

Ready to apply these insights? Here are actionable takeaways:

• Monitor key biomarkers regularly, treating your health like a financial portfolio to catch risks early.

• Incorporate evidence-based habits: Prioritise aerobic exercise, strength training, and stress reduction.

• Stay informed on emerging tools, such as advanced cell detection methods, through credible scientific updates.

• Consider consulting professionals for personalised interventions, including proven metabolic supports.

• Advocate for data-driven health policies to support large-scale longevity research.